HCV, HBV, and HIV seroprevalence, coinfections, and related behaviors among male injection drug users in Arak, Iran

References

• Alter, M. J., Kruszon-Moran, D., Nainan, O. V., McQuillan, G. M., Gao, F., Moyer, L. A., … Margolis, H. S. (1999). The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. The New England Journal of Medicine, 341, 556–562. doi:10.1056/NEJM199908193410802
   PubMed Web of Science ®Google Scholar
• Alter, M. J., & Moyer, L. A. (1998). The importance of preventing hepatitis C virus infection among injection drug users in the United States. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 18(Suppl. 1), S6–S10. doi:10.1097/00042560-199802001-00003
   Google Scholar
• Amin-Esmaeli, M., Rahimi-Movaghar, A., Razaghi, E. M., Baghestani, A. R., & Jafari, S. (2012). Factors correlated with hepatitis C and B virus infections among injecting drug users in Tehran, IR Iran. Hepatitis Monthly, 12, 23–31.
   Google Scholar
• Degenhardt, L., & Hall, W. (2012). What we know about the extent of illicit drug use, dependence, and their contribution to the global burden of disease. The Lancet, 379, 55–70. doi:10.1016/S0140-6736(11)61138-0
   PubMed Web of Science ®Google Scholar
• Kassaian, N., Adibi, P., Kafashaian, A., Yaran, M., Nokhodian, Z., Shoaei P., … Ataei, B. (2012). Hepatitis C virus and associated risk factors among prison inmates with history of drug injection in Isfahan, Iran. International Journal of Preventive Medicine, 3(Suppl. 1), S156–S161.
   Google Scholar
• Kheirandish, P., SeyedAlinaghi, S., Jahani, M., Shirzad, H., Seyed Ahmadian, M., Majidi, A., … McFarland, W. (2009). Prevalence and correlates of hepatitis C infection among male injection drug users in detention, Tehran, Iran. Journal of Urban Health, 86, 902–908. doi:10.1007/s11524-009-9393-0
   PubMed Web of Science ®Google Scholar
• Mahanta, J., Borkakoty, B., Das, H. K., & Chelleng, P. K. (2009). The risk of HIV and HCV infections among injection drug users in northeast India. AIDS Care, 21, 1420–1424. doi:10.1080/09540120902862584
   PubMed Web of Science ®Google Scholar
• Mathers, B. M., Degenhardt, L., Phillips, B., Wiessing, L., Hickman, M., Strathdee, S. A., … Mattick, R. P. (2008). Global epidemiology of injecting drug use and HIV among people who inject drugs: A systematic review. The Lancet, 372, 1733–1745. doi:10.1016/S0140-6736(08)61311-2
   PubMed Web of Science ®Google Scholar
• Ministry of Health (MoH). (2011). Current statistics on HIV/AIDS infection in Islamic Republic of Iran [ in Persian]. Tehran: Center for Disease Management, MoH.
   Google Scholar
• Mir-Nasseri, M. M., Mohammadkhani, A., Tavakkoli, H., Ansari, E., & Poustchi, H. (2011). Incarceration is a major risk factor for blood-borne infection among intravenous drug users: Incarceration and blood borne infection among intravenous drug users. Hepatitis Monthly, 11(1), 19–22.
   Web of Science ®Google Scholar
• Mohtasham Amiri, Z., Rezvani, M., Jafari Shakib, R., & Jafari Shakib, A. (2007). Prevalence of hepatitis C virus infection and risk factors of drug using prisoners in Guilan province. Eastern Mediterranean Health, 13, 250–256.
   PubMedGoogle Scholar
• Nelson, P. K., Mathers, B. M., Cowie, B., Hagan, H., Des Jarlais, D., Horyniak, D., & Degenhardt, L. (2011). Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: Results of systematic reviews. The Lancet, 378, 571–583. doi:10.1016/S0140-6736(11)61097-0
   PubMed Web of Science ®Google Scholar
• Rockstroh, J. K., & Spengler, U. (2004). HIV and hepatitis C virus co-infection. Lancet Infection Disease, 4, 437–44. doi:10.1016/S1473-3099(04)01059-X
   PubMed Web of Science ®Google Scholar
• Rowhani-Rahbar, A., Rooholamini, S., & Khoshnood, K. (2004). Prevalence of HIV infection and other blood-borne infections in incarcerated and non-incarcerated injection drug users (IDUs) in Mashhad, Iran. International Journal of Drug Policy, 15, 151–155. doi:10.1016/j.drugpo.2003.07.001
   Google Scholar
• Samuel, M. C., Doherty, P. M., Bulterys, M., & Jenison, S. A. (2001). Association between heroin use, needle sharing and tattoos received in prison with hepatitis B and C positivity among street recruited injecting drug users in New Mexico, USA. Epidemiology Infection, 127, 475–484. doi:10.1017/S0950268801006197
   PubMed Web of Science ®Google Scholar
• Skoretz, S., Zaniewski, G., & Goedhuis, N. J. (2004). Hepatitis C virus transmission in the prison/inmate population. Canada Communicable Disease Report, 30, 16–26.
   Google Scholar
• Sofian, M., Aghakhani, A., Banifazl, M., Azadmanesh, K., Farazi, A. A., McFarland, W., … Ramezani, A. (2012). Viral hepatitis and HIV infection among injection drug users in a central Iranian city. Journal of Addiction Medicine, 6, 292–296. doi:10.1097/ADM.0b013e3182659928
   PubMed Web of Science ®Google Scholar
• SPSS Inc. Released. (2007). SPSS for Windows, version 16.0. Chicago: Author.
   Google Scholar
• Stark, K., Bienzle, U., Vonk, R., & Guggenmoos-Holzmann, I. (1997). History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin. International Journal of Epidemiology, 26, 1359–1366. doi:10.1093/ije/26.6.1359
   PubMed Web of Science ®Google Scholar
• Xia, X., Luo, J., Bai, J., & Yu, R. (2008). Epidemiology of hepatitis C virus infection among injection drug users in China: Systematic review and meta-analysis. Public Health, 122, 990–1003. doi:10.1016/j.puhe.2008.01.014
   PubMed Web of Science ®Google Scholar